Equity Overview
Price & Market Data
Price: $1.18
Daily Change: -$0.02 / 1.69%
Daily Range: $1.16 - $1.21
Market Cap: $41,552,932
Daily Volume: 199,692
Performance Metrics
1 Week: 1.72%
1 Month: -21.33%
3 Months: -31.79%
6 Months: -46.12%
1 Year: -37.57%
YTD: -15.71%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country:
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.